CLINICAL TRIAL SOLUTIONS

Full Service: Phase II/III CRO

Get Phase II-III clinical trial support from a CRO that works collaboratively from start to end.

How can we support you?

Explore our Phase II-III CRO Services

PharPoint works diligently to help clients plan, manage, and analyze effective Phase II-III clinical trials. Whether you are looking for individual service support or looking to fully outsource your trial operations, our team is happy to chat.

Site Feasibility

Our analysis and insight can help sponsors effortlessly identify effective sites that can meet study goals.

Clinical Operations

Our team works to ensure study excellence and transparent collaboration between CRO, site, and Sponsor.

Clinical Data Management

Work with a clinical data management team that prioritizes your data from day one.

Biostatistics & Statistical Programming

Our consultative approach to biostatistics services includes a level of responsiveness, support, and proactiveness that is unmatched within the industry.

THE PHARPOINT DIFFERENCE

Helping sponsors meet their Phase II and Phase III study goals

AN EXPERIENCED TEAM

For Phase II-III Success

PharPoint aligns sponsors with teammates that have the right knowledge and experience to proactively identify factors critical to study success and mitigate potential study challenges. Working with the PharPoint team also means clear communication pathways and access to senior resources.

WORK COLLABORATIVELY

with a team that works without silos

From the start, the PharPoint team works collaboratively across functions to ensure study decisions are made with input from multiple perspectives. This connected approach helps us better anticipate challenges, accelerate timelines, and support deliverables that have our clients end goals in mind.

GET RESULTS FASTER

with PharPoint’s Industry-Best Biometrics Timelines

At every step, PharPoint’s standard biometrics CRO timelines are industry-best. Throughout your study, clean data are soft locked, reducing the number of subjects needing to be locked following Last Participant, Last Visit (LPLV) and decreasing the timeline to database lock to only 5 days after final Source Document Verification (SDV).